Home Health Drug Intervention Cuts Hospital Visits by 8%

Home health intervention with medication management can reduce hospital readmissions by as much as 8%, according to a joint study from national home health care provider Amedisys and Purdue University. The study, conducted from January 2012 through April 2012, reveals that a patient population utilizing medication intervention post-discharge had a 4% hospital admission rate, compared […]

Home Health Named Best Partner in Reducing Hospital Readmissions

Partnering with home health care agencies is emerging as a new model of care and a core strategy in preventing hospital readmissions, according to a new survey. Home health partnerships were the number-one strategy that 73% of senior hospital leaders adopt to lower preventable readmissions, as noted in a survey conducted by HealthLeaders Media Intelligence […]

Amedisys Reports 2Q Earnings Slump

Home health care and hospice provider Amedisys (NASDAQ: AMED) today announced adjusted earnings from continuing operations down 38% in the second quarter to $5.4 million or $0.17 per diluted share. The adjusted results reflect the addition of exit activity costs, the gain on sale of care centers and legal fees associated with investigations, the company […]

Home Health Companies Fall Out of Wall Street Favor Following CMS Proposal

Publicly held home health companies faltered on Wall Street in response to an announcement last week from the Centers for Medicare and Medicaid Services proposing Medicare reimbursements to home health providers will fall 1.5% in 2014, or $290 million based on estimates. Public companies including Gentiva Health Services (NASDAQ: GTIV) and Amedisys Inc. (NASDAQ: AMED) […]

Amedisys Prepares to Divest 35 Home Health Care Centers

Amedisys Inc. (NASDAQ: AMED) announced Friday it has retained a mergers and acquisitions company to help divest dozens of care centers in the coming months.  A nationwide health care at home company that currently covers 380,000 patients, Amedisys announced in its first quarter earnings statement it was planning to divest 50 of its care properties, […]

Reimbursement Pressures Drag Amedisys Earnings Down 51% in Q4

Home health and hospice company Amedisys, Inc. (NASDAQ:AMED) reported a net income of $7.2 million for the fourth quarter ended Dec. 31, 2012 on an adjusted basis, a 50.5% decrease from the previous year’s fourth quarter proceeds of $14.5 million.   For all of 2012, earnings attributable to Amedisys were down nearly 51% to $32.8 million. […]

Amedisys Responds to Wall Street Journal on Hospital Readmissions Problem

An article posted last week by the Wall Street Journal reported that the steps to reducing hospital readmission rates is “without an easy fix.” Detailing recent studies linking readmission rates to poor post-care coordination, the article caught the attention of Amedisys’ Chief Medical Officer Michael Fleming, MD, FAAFP. Because the nation’s healthcare needs are changing, Fleming […]

Gentiva, Amedisys Among Top Home Health Providers in 2012

The 2012 HomeCare Elite list was announced last week, ranking the top 100 and top 500 home health agencies in the nation. Gentiva Health Services, Amedisys Home Health, and Maxim Healthcare Services topped the list this year.  Using publicly available data from Home Health Compare and the Centers for Medicare & Medicaid Services (CMS), OCS […]

Medicare Cuts Drive Amedisys Q2 Profits Down

Amedisys, Inc. (NASDAQ: AMED), provider of home health and hospice care, suffered a 65.8% decline in earnings per share (EPS), during the second quarter of 2012 due to large cuts in Medicare reimbursements and the implementation of Medicare’s face-to-face law, according the company’s second quarter financial report. Despite decline to an EPS of 27 cents, the company […]